Venkataraman Sriram

CIK 00015506425 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001550642

Recent Transactions

36 trades

Other
RVL Pharmaceuticals plc
Ordinary Shares
2023-01-27−1,032,995→ 0 total
Purchase
RVL Pharmaceuticals plc
Ordinary Shares
2022-08-08$1.55/sh+8,000,000→ 23,730,864 total
Other
RVL Pharmaceuticals plc
Ordinary Shares
2020-11-20−4,936,926→ 0 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-06-10$5.65/sh+14,439→ 14,439 total
Purchase
RVL Pharmaceuticals plc
Ordinary Shares
2020-01-13$5.00/sh+1,250,000→ 15,730,864 total
Sale
OptiNose, Inc.
Common Stock
2019-11-25$9.16/sh−70,762→ 807,995 total
Sale
OptiNose, Inc.
Common Stock
2019-11-25$9.16/sh−887,722→ 10,136,374 total
Sale
OptiNose, Inc.
Common Stock
2019-11-25$9.16/sh−291,516→ 3,328,648 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2019-06-06$6.60/sh+14,439→ 14,439 total
Sale
OptiNose, Inc.
Common Stock
2018-06-11$20.91/sh−2,041,759→ 11,024,096 total
Sale
OptiNose, Inc.
Common Stock
2018-06-11$20.91/sh−670,487→ 3,620,164 total
Sale
OptiNose, Inc.
Common Stock
2018-06-11$20.91/sh−162,754→ 878,757 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2018-06-07$22.50/sh+14,439→ 14,439 total
Conversion
OptiNose, Inc.
Series C-2 Convertible Preferred Stock
2017-10-17−116,529→ 0 total
Conversion
OptiNose, Inc.
Series C-2 Convertible Preferred Stock
2017-10-17−354,855→ 0 total
Award
OptiNose, Inc.
Common Stock
2017-10-17$16.00/sh+887,721→ 988,292 total
Conversion
OptiNose, Inc.
Common Stock
2017-10-17+962,735→ 1,041,511 total
Conversion
OptiNose, Inc.
Common Stock
2017-10-17+12,077,563→ 13,065,855 total
Conversion
OptiNose, Inc.
Series C Convertible Preferred Stock
2017-10-17−2,786,097→ 0 total
Conversion
OptiNose, Inc.
Common Stock
2017-10-17+3,966,107→ 4,290,651 total
Conversion
OptiNose, Inc.
Series D Convertible Preferred Stock
2017-10-17−216,189→ 0 total
Award
OptiNose, Inc.
Common Stock
2017-10-17$16.00/sh+291,516→ 4,290,651 total
Conversion
OptiNose, Inc.
Series C-1 Convertible Preferred Stock
2017-10-17−824,986→ 0 total
Conversion
OptiNose, Inc.
Series C-2 Convertible Preferred Stock
2017-10-17−28,286→ 0 total
Award
OptiNose, Inc.
Common Stock
2017-10-17$16.00/sh+70,763→ 1,041,511 total
Conversion
OptiNose, Inc.
Series C Convertible Preferred Stock
2017-10-17−914,916→ 0 total
Conversion
OptiNose, Inc.
Series C-1 Convertible Preferred Stock
2017-10-17−270,915→ 0 total
Conversion
OptiNose, Inc.
Series C Convertible Preferred Stock
2017-10-17−222,089→ 0 total
Conversion
OptiNose, Inc.
Series C-1 Convertible Preferred Stock
2017-10-17−65,761→ 0 total
Conversion
OptiNose, Inc.
Series D Convertible Preferred Stock
2017-10-17−17,233→ 0 total
Sale
Lantheus Holdings, Inc.$LNTH
Common Stock
2017-03-17$12.20/sh−1,709,278→ 7,004,395 total
Sale
Lantheus Holdings, Inc.$LNTH
Common Stock
2017-03-17$12.20/sh−840,000→ 3,442,208 total
Sale
Lantheus Holdings, Inc.$LNTH
Common Stock
2017-03-17$12.20/sh−450,722→ 1,846,996 total
Sale
Lantheus Holdings, Inc.$LNTH
Common Stock
2016-11-21$9.00/sh−1,424,399→ 8,713,673 total
Sale
Lantheus Holdings, Inc.$LNTH
Common Stock
2016-11-21$9.00/sh−700,000→ 4,282,208 total
Sale
Lantheus Holdings, Inc.$LNTH
Common Stock
2016-11-21$9.00/sh−375,601→ 2,297,718 total

Companies

Recent Filings

Address

C/O AVISTA CAPITAL PARTNERS 65 E. 55TH STREET, 18TH FLOOR

NEW YORK, NY, 10022

View on SEC.gov